Tag: lab automation in drug discovery market outlook

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Lab Automation In Drug Discovery Market from 2024 to 2025?

The lab automation in drug discovery sector has seen a robust expansion in recent times. The market which was valued at $6.47 billion in 2024, is projected to increase to $6.81 billion in 2025, witnessing a compound annual growth rate (CAGR) of 5.3%. The surge in the earlier period was driven by several factors including the growing complexity of drug discovery, the need for efficiency and cost effectiveness, the increasing demand for high-throughput screening, escalating labor costs and the urgency to speed up drug development timelines.

What Is the Projected Market Size of the Lab Automation In Drug Discovery Market?

The size of the lab automation in drug discovery market is predicted to experience significant growth in the coming years. With an estimated worth of $8.4 billion in 2029 and a compound annual growth rate of 5.4%, the market’s progress during the forecast period is largely credited to the expansion of pharmaceutical companies’ drug pipelines, increasing personalized medicine and precision therapeutics, heightened focus on rare diseases and orphan drugs, and the demand for de-centralized clinical trials and remote-led experiments. Additionally, the rise of microfluidics and lab-on-a-chip technologies also contribute to this growth. Regarding the upcoming trends within the forecast period, they encompass the adoption of flexible and customizable automation solutions, cloud-based platforms as a medium of data management and collaboration, automation’s growth in emerging markets, the surfacing of virtual drug discovery companies which exploit automation and digital technologies, alongside the creation of standardized protocols and systems that are compatible with each other.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

Who are the Major Competitors in the Lab Automation In Drug Discovery Market Outlook?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

What Is Fueling Growth in the Lab Automation In Drug Discovery Market?

The surge in need for precision medicine is pushing the growth of lab automation in the drug discovery market. Personalized or precision medicine is a method of medical prevention and treatment that considers genetic, environmental, and lifestyle individual differences. Lab automation speeds up research, enhances research repeatability, and increases the efficiency of precision medicine and drug discovery practices, eventually resulting in the production of drugs and diagnostics tailored to individual patients. For example, the Personalized Medicine Coalition (PMC), which is a US-based organization advocating the understanding and implementation of personalized medicine, revealed in October 2022 that over 75,000 genetic testing products and 300 personalized medicines for several types of cancer, rare genetic diseases, and various chronic and infectious diseases would be available in the market. Consequently, the rising demand for precision medicine is stimulating the expansion of lab automation in the drug discovery market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Which Lab Automation In Drug Discovery Market Segments Are Growing the Fastest?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Which Industry Trends Are Shaping the Future of the Lab Automation In Drug Discovery Market?

Key organizations in the drug discovery lab automation market are increasing their emphasis on innovation, particularly the creation of advanced solutions like fast idea-to-data solutions, as a strategy to maintain a competitive advantage. Rapid idea-to-data solutions equate to efficient processes or platforms enabling the speedy conversion of individual or collective ideas into practical insights or data-informed results. An example of this was seen in April 2022 when Strateos Inc., a biotech company based in the US, introduced a quick idea-to-data solution for small molecule discovery integrated into its cloud lab automation platform as a service. This lab automation tool is tailored specifically for small-molecule discovery within drug development. This flexible, on-demand Strateos Cloud Lab Automation-as-a-Service Platform is equipped with a connected robotic automation system with 23 workcells and hundreds of devices. The platform aids in accelerating early lead generation through optimization, facilitated by a software framework enabling automated assembly and testing of user-designed compounds in the cloud through various methods like cell-based, biochemical, and SAR assessments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Countries Are Leading the Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410

This Report Delivers Insight On:

1. How big is the lab automation in drug discovery market, and how is it changing globally?

2. Who are the major companies in the lab automation in drug discovery market, and how are they performing?

3. What are the key opportunities and risks in the lab automation in drug discovery market right now?

4. Which products or customer segments are growing the most in the lab automation in drug discovery market?

5. What factors are helping or slowing down the growth of the lab automation in drug discovery market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the lab automation in drug discovery industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What is the Projected CAGR for the Lab Automation In Drug Discovery Market Size from 2025 to 2034?

In recent times, there has been a robust expansion in the market size of lab automation in drug discovery. The market, which is expected to surge from $6.47 billion in 2024 to $6.81 billion in 2025, is projected to register a compound annual growth rate (CAGR) of 5.3%. This growth observed in the historic period is attributable to factors such as the rising complexity in drug discovery, the need for operational efficiency and cost cutbacks, an increasing demand for high-throughput screening, mounting labor expenses, and urgency to hasten the timelines of drug development.

In the coming years, the lab automation in drug discovery market is projected to experience significant expansion, poised to rise to $8.4 billion by 2029, marking a compound annual growth rate (CAGR) of 5.4%. This predicted growth during the forecast period is largely driven by factors such as the broadening drug portfolios of pharmaceutical firms, the escalation in personalized medicine and precision therapeutics, heightened focus on unique diseases and specialized drugs, surging demand for off-site and decentralized clinical trials, and the advent of microfluidics and lab-on-a-chip technologies. Predominant trends in the forecast period consist of the spread of customizable and modular automation solutions, the uptake of cloud-based platforms for data collaboration and management, automation growth in emerging markets, the emergence of virtual drug discovery companies exploiting automation and digital technologies, and the formulation of standardized protocols and interoperable systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Lab Automation In Drug Discovery Market?

The surge in the need for precision medicine is predicted to fuel the expansion of lab automation within the drug discovery market. Precision, or personalized, medicine is a medical treatment and prevention approach that considers the unique variations in genes, environment, and lifestyle for each person. Lab automation expedites research, enhances experimental consistency, and boosts precision medicine and drug discovery procedures’ efficiency, thereby resulting in the development of more efficient medicines and diagnostics tailored to individual patients. For example, as of October 2022, the Personalized Medicine Coalition (PMC), a US-centric organization advocating for the understanding and adoption of personalized medicine, reports that over 75,000 genetic testing products and 300 personalized medicines will be available in the market for individuals with diverse types of cancer, rare genetic diseases, and a variety of chronic and infectious diseases. Consequently, the escalating demand for precision medicine is propelling the expansion of lab automation in the drug discovery market.

Which Primary Segments of the Lab Automation In Drug Discovery Market Are Driving Growth and Industry Transformations?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Which Regions Are Key Players in the Growth of the Lab Automation In Drug Discovery Market?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Lab Automation In Drug Discovery Market?

Leading organizations in the lab automation sector of drug discovery are concentrating more on creating advanced solutions, such as rapid idea-to-data solutions, to gain a competitive advantage. A rapid idea-to-data solution is a simplified process or platform that aids individuals or organizations in swiftly transitioning their concepts or ideas into actionable knowledge or data-based outcomes. For example, in April 2022, Strateos Inc., a biotechnology firm based in the US, rolled out a rapid idea-to-data solution for small molecule discovery on its cloud-based lab automation-as-a-service platform. This lab automation tool is tailor-made for small-molecule discovery during drug development. The flexible, scalable Strateos Cloud Lab Automation-as-a-Service Platform features connected robotic automation with 23 workcells and hundreds of devices. The platform supports early lead generation to lead optimization, managed by software architecture that lets users design compounds of interest in the cloud and have them auto-assembled and evaluated using an array of methods like cell-based, biochemical, and structured-activity relationship (SAR) evaluations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

What Parameters Are Used to Define the Lab Automation In Drug Discovery Market?

Lab automation in drug discovery refers to the use of advanced technologies and robotics to streamline and optimize laboratory processes related to new drug development and research. It is used to significantly enhance the speed and success rate of drug discovery efforts by automating repetitive tasks and integrating advanced instruments and software.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Lab Automation In Drug Discovery Market?

The surge in demand for precision medicine is projected to fuel the expansion of lab automation in the drug discovery sector. Precision or personalized medicine entails an approach towards prevention and medical treatment that factors in each person’s unique gene, environment, and lifestyle variation. The application of lab automation enhances research, boosts experimental consistency, and optimizes the effectiveness of precision medicine and drug discovery methods. The end result is the production of more beneficial medicines and diagnostic tools tailored to the needs of individual patients. For example, the Personalized Medicine Coalition (PMC), a US organization advocating for the understanding and implementation of personalized medicine, reported in October 2022 that over 75,000 genetic testing products and 300 personalized medicines would be available in the market, targeting multiple cancer types, rare genetic diseases, and various chronic and infectious diseases. Consequently, the escalating demand for precision medicine prompts the growth of lab automation in the drug discovery sector.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What is the Predicted Annual Growth Rate of theLab Automation In Drug Discovery Market Impact Industry Trends by 2034?

Recent years have seen a robust expansion of the lab automation in drug discovery market. The market’s value, which is projected to reach $6.47 billion by 2024, is expected to increase further to $6.81 billion by 2025, indicating a compound annual growth rate (CAGR) of 5.3%. Factors such as the rising complexities in drug discovery, the need for more efficient and cost-effective methods, surging demand for high-throughput screening, escalating labor costs, and the urgency to hasten drug development timelines have all contributed to significant growth during the historic period.

The lab automation in drug discovery market is predicted to experience significant growth in the coming years, with anticipation to reach $8.4 billion by 2029, progressing at a compound annual growth rate (CAGR) of 5.4%. This growth during the forecast period is attributed to factors such as the expansion of pharmaceutical firms’ drug pipelines, increased interest in personalized medicine and precision therapeutics, a heightened focus on rare diseases and orphan drugs, and demand for remote and decentralized clinical trials, coupled with the rise of microfluidics and lab-on-a-chip technologies. The imminent trends to dominate the projected period include the widespread adoption of modular and customizable automation solutions, the use of cloud platforms for data management and collaboration, expansion of automation in nascent markets, evolution of virtual drug discovery businesses utilizing automation and digital helpers, and creation of standardized, interoperable systems.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410

What Are the Most Significant Market Trends Transforming theLab Automation In Drug Discovery Market?

Top firms in the drug discovery lab automation market are intensifying their efforts to create innovative solutions, including rapid idea-to-data solutions, to maintain their market dominance. Rapid idea-to-data solutions refer to an efficient platform or procedure that enables individuals or businesses to swiftly convert their ideas or designs into actionable information or data-driven outcomes. For example, in April 2022, Strateos Inc., an American biotech firm, introduced a fast idea-to-data solution for small molecule discovery on its cloud lab automation-as-a-service platform. This lab automation tool is custom-made for small-molecule discovery in drug development. The adaptable, on-demand Strateos Cloud Lab Automation-as-a-Service Platform comprises connected robotic automation with 23 workcells and countless instruments. This platform aids in early lead generation through lead optimization, steered by a software structure that lets users create compounds of interest in the cloud. These compounds are then automatically assembled and tested through various techniques such as cell-based, biochemical, and structured-activity relationship (SAR) evaluations.

What Are the Top Market Players Propelling the Growth of theLab Automation In Drug Discovery Industry?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Which Primary Segments of the Lab Automation In Drug Discovery Market Are Driving Growth and Industry Transformations?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Lab Automation In Drug Discovery Market?# Market?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Lab Automation In Drug Discovery Market 2025, By The Business Research Company:

Network Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-automation-global-market-report

Intelligent Building Automation Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intelligent-building-automation-technologies-global-market-report

Security Orchestration, Automation And Response (SOAR) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/security-orchestration-automation-and-response-soar-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the Lab Automation In Drug Discovery market?

The market size for lab automation in drug discovery has witnessed significant growth in the past few years. The market value is expected to increase from $6.47 billion in 2024 to an anticipated $6.81 billion in 2025, following a compound annual growth rate (CAGR) of 5.3%. Factors contributing to this growth during the historic period include the escalating complexity of drug discovery, mounting demand for cost and efficiency optimisation, the expanding necessity for high-throughput screening, increasing labor costs, and a pressing need to hasten drug development timelines.

What will be the lab automation in drug discovery market size in the future?

We anticipate a robust expansion in the size of the lab automation in drug discovery market in the coming years. By 2029, the market is predicted to escalate to $8.4 billion at an annual compound growth rate (CAGR) of 5.4%. The growth in the predicted period can be connected to the expansion of drug pipelines in pharmaceutical firms, increase in bespoke medicine and precision therapeutics, escalating focus on uncommon diseases and orphan drugs, increasing demand for remote and decentralized clinical trials, and the emergence of microfluidic and lab-on-a-chip technologies. The forecast period will likely see a surge in modular and customizable automation solutions, the uptake of cloud-based platforms for data collaboration and management, growth of automation in budding markets, rise of digital virtual drug discovery firms using automation and advancement in standardized protocols and interoperable systems.

Get your lab automation in drug discovery market report here!

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

What main drivers are fueling expansion in the lab automation in drug discovery market?

As precision medicine’s demand continues to surge, lab automation in the drug discovery market is set for significant expansion. Precision medicine or personalized medicine bases its prevention and treatment strategies on the unique variations in an individual’s genes, environment, and lifestyle. Through lab automation, research gets a speed boost, repeatability of experiments is enhanced, and the efficiency of precision medicine and drug discovery processes improves. As a result, more tailored and efficient drugs and diagnostics are developed for individual patients. Take, for example, the Personalized Medicine Coalition (PMC), a US-oriented entity advocating for personalized medicine understanding and uptake. They believe that by October 2022, the market will house over 75,000 genetic testing products and 300 personalized medications for a variety of conditions, including multiple cancer types, rare genetic diseases, and several chronic and infectious diseases. Therefore, the rising interest in precision medicine fuels lab automation’s growth in the drug discovery market.

What key areas define the segmentation of the global lab automation in drug discovery market?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

Who are the dominant players expanding their reach in the lab automation in drug discovery market?

Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

How are evolving market trends shaping lab automation in drug discovery Strategies?

Leading firms within the lab automation in the drug discovery industry are shifting their attention towards the creation of cutting-edge solutions like rapid idea-to-data solutions to maintain a competitive advantage. Rapid idea-to-data solutions are streamlined processes or platforms that efficiently convert ideas or concepts into actionable information or data-driven outcomes. For example, Strateos Inc., a biotech firm located in the United States, rolled out a rapid idea-to-data solution aimed at small molecule discovery on its cloud lab automation-as-a-service platform in April 2022. This specialized lab automation tool is purposely built for small-molecule discovery during drug development. It is featured on the highly scalable Strateos Cloud Lab Automation-as-a-Service Platform, which integrates 23 robotic automation workcells and several hundred instruments. The platform supports the initial generation of lead compounds and their optimization through a software architecture enabling users to develop compounds of interest in cloud. These are then automatically composed and evaluated using a range of methodologies, including cell-based, biochemical and Structure-Activity Relationship (SAR) assessments.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410

Which regions are emerging as leaders in the lab automation in drug discovery market?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Network Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-automation-global-market-report

Intelligent Building Automation Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intelligent-building-automation-technologies-global-market-report

Security Orchestration, Automation And Response (SOAR) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/security-orchestration-automation-and-response-soar-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Lab Automation In Drug Discovery Market Over the Coming Decade?

In the past few years, there has been a considerable expansion in the size of the lab automation in drug discovery market. It is projected to increase from a value of $6.47 billion in 2024 to $6.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.3%. The driving forces behind this strong growth trend during the historic period are rising complexity in drug discovery, a heightened demand for cost and efficiency improvements, an increase in the requirement for high throughput screening, escalating labor expenses, and an urgency to hasten the timelines for developing drugs.

The market for lab automation in drug discovery is set to witness robust expansion in the coming years, with projections indicating a growth to $8.4 billion by 2029 at a compound annual growth rate (CAGR) of 5.4%. This projected growth during the forecast period is largely driven by factors such as the broadening drug pipelines of pharmaceutical firms, the increasing prevalence of personalized and precision medicine, a heightened focus on rare diseases and orphan drugs, demand for remote and decentralized clinical trials, and the advent of microfluidics and lab-on-a-chip technologies. Key trends predicted for this forecasted period consist of the widespread adoption of modular and customizable automation solutions, the shift to cloud-based platforms for managing data and fostering collaboration, the rise in automation in emerging markets, the emergence of virtual drug discovery firms availing the benefits of automation and digital tech, along with the development of standardized protocols and interoperable systems.

What Combination of Drivers Is Leading to Accelerated Growth in the lab automation in drug discovery Market?

The surging necessity for precision medicine is anticipated to stimulate the expansion of lab automation in the drug discovery market in the future. Precision medicine or personalized medicine represents a treatment and prevention approach in medicine that considers individual differences in genes, environment, and lifestyle. Lab automation enhances research, boosts experimental repeatability, and heightens the efficiency of precision medicine and drug discovery methods, consequently resulting in the development of more apt medicines and diagnoses for individual patients. For example, in October 2022, the Personalized Medicine Coalition (PMC), an American entity advocating for the understanding and utilization of personalized medicine, reported that more than 75,000 genetic testing products and 300 personalized medicines will be available for those suffering from various types of cancer, uncommon genetic diseases, and a spectrum of chronic and infectious diseases. Hence, the escalating demand for precision medicine is propelling the advancement of lab automation in the drug discovery market.

Explore Comprehensive Insights Into The Global Lab Automation In Drug Discovery Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Are the Major Players Making an Impact in the Lab Automation In Drug Discovery Market’s Growth?

Major companies operating in the lab automation in drug discovery market are:

• Thermo Fisher Scientific Inc._x000D_

• Abbott Diagnostics_x000D_

• Roche Holdings Inc._x000D_

• Beckman Coulter_x000D_

• Siemens Healthineers_x000D_

Which Upcoming Trends Are Set to Influence the Lab Automation In Drug Discovery Market’s Path Forward?

Principal businesses involved in lab automation for the drug discovery sector are intensifying their efforts in creating innovative solutions like the rapid idea-to-data solutions. This term refers to a simplified procedure or platform that swiftly transforms concepts or ideas into actionable data-driven results or insights. For example, in April 2022, Strateos Inc., a biotech firm based in the US, introduced a rapid idea-to-data solution specifically intended for small molecule discovery on its cloud lab automation-as-a-service platform. This platform is a lab automation utility specifically tailored for small molecule discovery in the area of drug development. The flexible, on-demand Strateos Cloud Lab Automation-as-a-Service platform incorporates interlinked robotic automation with 23 workcells and several instruments. It eases the process of early lead generation up to lead optimization, controlled by a software framework that lets users design desired compounds in the cloud. These designed compounds can then be automatically constructed and tested through various techniques like cell-based, biochemical, and structured-activity relationship (SAR) assessments.

Secure Your Global Lab Automation In Drug Discovery Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

How Are Market Segments in the Lab Automation In Drug Discovery Industry Positioned for Long-Term Growth?

The lab automation in drug discovery market covered in this report is segmented –

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types

2) By Component: Instruments, Software, Services

3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications

4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:

1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations

2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems

3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots

4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems

5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

What Regions Are Steering Growth in the Lab Automation In Drug Discovery Sector?

North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Lab Automation In Drug Discovery Market Classified and Defined in Market Analysis?

Lab automation in drug discovery refers to the use of advanced technologies and robotics to streamline and optimize laboratory processes related to new drug development and research. It is used to significantly enhance the speed and success rate of drug discovery efforts by automating repetitive tasks and integrating advanced instruments and software.

Browse Through More Similar Reports By The Business Research Company:

Network Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/network-automation-global-market-report

Intelligent Building Automation Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intelligent-building-automation-technologies-global-market-report

Security Orchestration, Automation And Response (SOAR) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/security-orchestration-automation-and-response-soar-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: